NCT06338202View on ClinicalTrials.gov

Real-World Effectiveness of Mavacamten in Canada

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Interventions
DRUG

Mavacamten

As detailed in the product label

Trial Locations (1)

N6A 5A5

RECRUITING

London Health Science Centre (LHSC), London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06338202 - Real-World Effectiveness of Mavacamten in Canada | Biotech Hunter | Biotech Hunter